文献速递慢阻肺

慢阻肺合并症的超额经济负担:一项15年人群研究

Excess economic burden of comorbidities in COPD: a 15-year population-based study.
PubMed 文献 · Eur Respir J · 2017-07-27

慢阻肺患者每人年超额直接医疗费用为5196加元(3668欧元),其中51%归因于合并症,26%归因于慢阻肺本身,23%无法归因于特定疾病。超额住院费用是主要驱动因素。

要点

  • 慢阻肺患者每人年超额直接医疗费用为5196加元(3668欧元),51%由合并症贡献。
  • 超额住院费用是慢阻肺经济负担的主要驱动因素。
  • 合并症中循环系统疾病、其他呼吸系统疾病、消化系统疾病和心理疾病贡献最大。

核心结论

  • 慢阻肺患者合并症的超额经济负担显著,预防和适当管理合并症可能有效减轻慢阻肺总体负担。

研究设计与样本

  • 根据国际疾病分类代码将卫生服务使用记录归纳为16个主要疾病类别。
  • 超额费用估计为两组间直接医疗费用的调整差值,以2015年加元计并转换为2015年欧元(CAD1.000=EUR 0.706)。

主要发现

  • 慢阻肺患者每人年超额直接医疗费用为CAD5196/EUR3668(95% CI CAD3540-8529)。
  • 超额费用中26%归因于慢阻肺本身,51%归因于合并症,23%无法归因于任何特定疾病。
  • 超额住院费用是主要费用驱动因素。
  • 合并症费用最大组成部分为循环系统疾病(CAD696/EUR491每人年)、其他呼吸系统疾病(CAD312/EUR220每人年)、消化系统疾病(CAD274/EUR193每人年)和心理疾病(CAD249/EUR176每人年)。

临床怎么用

  • 临床管理慢阻肺患者时应重视合并症的预防和适当管理,可能有助于降低总体经济负担。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

A better understanding of the true burden of chronic obstructive pulmonary disease (COPD) needs to consider the implications of comorbidities. This study comprehensively examined the impact of comorbidities on excess direct medical costs in COPD patients.From health administrative data in British Columbia, Canada (1996-2012), we created a propensity-score-matched cohort of incident COPD patients and individuals without COPD. Health services use records were compiled into 16 major disease categories based on International Classification of Diseases codes. Excess costs (in 2015 Canadian dollars and converted to 2015 Euros; CAD1.000=EUR 0.706) were estimated as the adjusted difference in direct medical costs between the two groups.The sample included 128 424 subjects in each group. COPD patients generated excess costs of CAD5196/EUR3668 per person-year (95% CI CAD3540-8529), of which 26% was attributable to COPD itself and 51% was attributable to comorbidities (the remaining 23% could not be attributed to any specific condition). The major cost driver was excess hospitalisation costs. The largest components of comorbidity costs were circulatory diseases, other respiratory disorders, digestive disorders and psychological disorders (CAD696/EUR491, CAD312/EUR220, CAD274/EUR193 and CAD249/EUR176 per person-year, respectively).These findings suggest that the prevention and appropriate management of comorbidities in COPD patients may effectively reduce the overall burden of COPD.

来源:Eur Respir J,查看原文。版权归原作者所有。

引用

  1. Chen W, FitzGerald JM, Sin DD, et al. Excess economic burden of comorbidities in COPD: a 15-year population-based study. Eur Respir J. 2017. PMID: 28751416. doi:10.1183/13993003.00393-2017

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。